000097135 001__ 97135
000097135 005__ 20220511133126.0
000097135 0247_ $$2doi$$a10.1038/s41598-020-76546-9
000097135 0248_ $$2sideral$$a121111
000097135 037__ $$aART-2020-121111
000097135 041__ $$aeng
000097135 100__ $$aGuerrero Fernández de Alba, I.
000097135 245__ $$aAssociation between mental health comorbidity and health outcomes in type 2 diabetes mellitus patients
000097135 260__ $$c2020
000097135 5060_ $$aAccess copy available to the general public$$fUnrestricted
000097135 5203_ $$aType 2 diabetes mellitus (T2D) is often accompanied by chronic diseases, including mental health problems. We aimed at studying mental health comorbidity prevalence in T2D patients and its association with T2D outcomes through a retrospective, observational study of individuals of the EpiChron Cohort (Aragón, Spain) with prevalent T2D in 2011 (n = 63, 365). Participants were categorized as having or not mental health comorbidity (i.e., depression, anxiety, schizophrenia, and/or substance use disorder). We performed logistic regression models, controlled for age, sex and comorbidities, to analyse the likelihood of 4-year mortality, 1-year all-cause hospitalization, T2D-hospitalization, and emergency room visit. Mental health comorbidity was observed in 19% of patients. Depression was the most frequent condition, especially in women (20.7% vs. 7.57%). Mortality risk was higher in patients with mental health comorbidity (odds ratio 1.24; 95% confidence interval 1.16–1.31), especially in those with substance use disorder (2.18; 1.84–2.57) and schizophrenia (1.82; 1.50–2.21). Mental health comorbidity also increased the likelihood of all-cause hospitalization (1.16; 1.10–1.23), T2D-hospitalization (1.51; 1.18–1.93) and emergency room visit (1.26; 1.21–1.32). These results suggest that T2D healthcare management should include specific strategies for the early detection and treatment of mental health problems to reduce its impact on health outcomes.
000097135 536__ $$9info:eu-repo/grantAgreement/ES/DGA-FEDER/B01-20R$$9info:eu-repo/grantAgreement/ES/DGA-FEDER/Construyendo Europa desde Aragón
000097135 540__ $$9info:eu-repo/semantics/openAccess$$aby$$uhttp://creativecommons.org/licenses/by/3.0/es/
000097135 590__ $$a4.379$$b2020
000097135 591__ $$aMULTIDISCIPLINARY SCIENCES$$b17 / 73 = 0.233$$c2020$$dQ1$$eT1
000097135 592__ $$a1.24$$b2020
000097135 593__ $$aMultidisciplinary$$c2020$$dQ1
000097135 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion
000097135 700__ $$0(orcid)0000-0002-5440-1710$$aGimeno-Miguel, A.
000097135 700__ $$aPoblador-Plou, B.
000097135 700__ $$0(orcid)0000-0003-2928-6623$$aGimeno-Feliu, L.A.$$uUniversidad de Zaragoza
000097135 700__ $$aIoakeim-Skoufa, I.
000097135 700__ $$aRojo-Martínez, G.
000097135 700__ $$aForjaz, M.J.
000097135 700__ $$aPrados-Torres, A.
000097135 7102_ $$11007$$2610$$aUniversidad de Zaragoza$$bDpto. Medicina, Psiqu. y Derm.$$cArea Medicina
000097135 773__ $$g10, 1 (2020), 19583 [9 pp]$$pSci. rep.$$tScientific Reports$$x2045-2322
000097135 8564_ $$s242127$$uhttps://zaguan.unizar.es/record/97135/files/texto_completo.pdf$$yVersión publicada
000097135 8564_ $$s316257$$uhttps://zaguan.unizar.es/record/97135/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000097135 909CO $$ooai:zaguan.unizar.es:97135$$particulos$$pdriver
000097135 951__ $$a2022-05-11-13:13:36
000097135 980__ $$aARTICLE